To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Madrigal Pharmaceuticals is ...

In November 2025, Madrigal Pharmaceuticals announced positive two-year results from the open-label compensated MASH cirrhosis arm of its Phase 3 MAESTRO-NAFLD-1 trial, showing statistically ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When Madrigal Pharmaceuticals secured its history-making ...

Delicacy and sensuality collided in Pepa Salazar’s latest collection. Moving effortlessly from soft pinks to daring sheers and weaving in floral prints, feathers, lace, and velvet, the designer built ...

Salt-N-Pepa has never dodged frankness. Even at their Rock & Roll Hall of Fame induction, the hip-hop pioneers took a moment from celebrating to put the music industry on blast. But along with ...

Hip-hop legends Salt-N-Pepa added one more monumental honor to their mantle with their induction into the Rock & Roll Hall of Fame as the recipients of this year’s Musical Influence Award. Both Cheryl ...

Pioneering female rap group Salt-N-Pepa, who are in the middle of a dispute over ownership of their masters, used their induction speeches at the Rock and Roll Hall of Fame ceremony on Saturday to ...

Salt-N-Pepa were inducted into the Rock & Roll Hall of Fame on Saturday night, with Missy Elliott leading the tribute to the trailblazing rap duo. During their acceptance speech, Cheryl “Salt” James ...

Madrigal (shoulder) cleared waivers and opted for free agency Thursday. Madrigal missed the full 2025 campaign after undergoing surgery in February to repair a fractured left shoulder. The infielder, ...

Madrigal Pharmaceuticals' Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment ...

Madrigal Pharmaceuticals is reiterated as a Strong Buy, driven by Rezdiffra's rapid US launch and recent European approval. Q2 2025 saw Rezdiffra sales reach $213M and >23,000 patients, with Q3 ...